Omar Siddiqi, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine

MD, Washington University School of Medicine

Pronouns: he/him/his



Omar Siddiqi, MD is an Assistant Professor of Medicine in Cardiovascular Medicine at the Boston University School of Medicine, and he is the Program Director of the Cardiovascular Medicine Fellowship Program. As director of the cardiology fellowship curriculum, he is credited with developing an academic half day for cardiovascular medicine fellows, developing an echocardiography curriculum utilizing the CAE echocardiography simulator housed in the Solomont Simulation Center, and starting an Imaging Show and Tell conference. These efforts have been recognized with two Cardiovascular Medicine Fellowship Faculty Teaching Awards which he won in 2015 and 2018. At the Boston University School of Medicine, he serves as co-director of the second year medical school cardiovascular pathophysiology module. His research interests in medical education include the development of simulation-based curricula and the integration of team-based learning (TBL) in teaching ECGs. His clinical interests include cardiac amyloidosis and echocardiography, and he is an attending cardiologist in the BU Amyloidosis Center. His clinical research interests are around the assessment of novel therapies for the treatment of cardiac amyloidosis. He has served as Clinical Investigator of five studies, including two currently.

Member
Boston University
Amyloidosis Center





A Phase 2, randomized, placebo-controlled, subject and investigator blinded, multi-center study…
06/09/2020 - 06/09/2023 (PI)
Novartis Pharma Corp

Myocardial ischemia and Transfusion (MINT)-CCC
06/01/2017 - 05/31/2022 (PI)
Rutgers, New Jersey Medical School NIH-NHLBI


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Siddiqi OK, Mints YY, Berk JL, Connors L, Doros G, Gopal DM, Kataria S, Lohrmann G, Pipilas AR, Ruberg FL. Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid. 2022 Jan 27; 1-8.View Related Profiles. PMID: 35083944
     
  2. Alreshq R, Tugal D, Siddiqi O, Ruberg F. Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review. Pacing Clin Electrophysiol. 2021 Dec; 44(12):2092-2099.View Related Profiles. PMID: 34632598
     
  3. Benbrahim M, Norman K, Sanchorawala V, Siddiqi OK, Hughes D. A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis. J Cardiovasc Pharmacol. 2021 05 01; 77(5):544-548.View Related Profiles. PMID: 33657048
     
  4. Lohrmann G, Patel MA, Brauneis D, Sanchorawala V, Sarosiek S, Vellanki N, Siddiqi OK, Ruberg FL, Gopal DM. Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation. JACC CardioOncol. 2020 Dec; 2(5):721-731.View Related Profiles. PMID: 33511355; PMCID: PMC7839967; DOI: 10.1016/j.jaccao.2020.10.010;
     
  5. Ruberg FL, Siddiqi OK. In Search of the Holy Grail: Evidence of Amyloid Fibril Regression in ATTR Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2021 01; 14(1):200-202.View Related Profiles. PMID: 33129738; PMCID: PMC8543316; DOI: 10.1016/j.jcmg.2020.08.021;
     
  6. Ruberg FL, Siddiqi OK. Hepatocyte Growth Factor and Cardiac Amyloidosis. JACC CardioOncol. 2020 Mar; 2(1):67-69.View Related Profiles. PMID: 32647833; PMCID: PMC7347296; DOI: 10.1016/j.jaccao.2020.02.004;
     
  7. Ruberg FL and Siddiqi OK. Hepatocyte Growth Factor and Cardiac Amyloidosis. JACC: Cardio Oncology. 2020; 2(1):67-69.
  8. Lohrmann G, Pipilas A, Mussinelli R, Gopal DM, Berk JL, Connors LH, Vellanki N, Hellawell J, Siddiqi OK, Fox J, Maurer MS, Ruberg FL. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis. J Card Fail. 2020 Sep; 26(9):753-759.View Related Profiles. PMID: 31805416; PMCID: PMC7758872; DOI: 10.1016/j.cardfail.2019.11.024;
     
  9. Gopal DM, Ruberg FL, Siddiqi OK. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Curr Heart Fail Rep. 2019 10; 16(5):180-188.View Related Profiles. PMID: 31520266
     
  10. Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309.View Related Profiles. PMID: 30664726
     
Showing 10 of 22 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 22 publications over 13 distinct years, with a maximum of 4 publications in 2020

YearPublications
20051
20071
20091
20111
20121
20131
20151
20172
20183
20193
20204
20212
20221


Common Heart Medications Do Not Increase COVID-19 Risks, Studies Say

WBUR 5/4/2020

2019 Boston University School of Medicine: Faculty of the Month Award
2019 Boston University School of Medicine: Extra Miler Award
2018 Boston Medical Center: Cardiology Fellowship Teaching Award
2015 Boston Medical Center: Cardiology Fellowship Teaching Award
Contact for Mentoring:

88 E. Newton St Newton Pavilion
Boston MA 02118
Google Map

617.638.8760
Download vCard

Siddiqi's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (115) concept(s)
_
Media Mentions
_
Co-Authors
See all (13) people
_
Similar People
See all (60) people
_
Same Department
Search Department